Skip to main content

Table 1 Patient characteristics

From: Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial

  Total Adult Children Placebo sc-LCPUFA
Subjects [n] 64 34 30 32 32
Female/Male [n] 35/29 22/12 13/17 16/16 19/13
Age [yrs] 19.0 ± 5.5 23.5 ± 3.0 13.8 ± 2.2 18.4 ± 5.0 19.5 ± 6.0
Weight [kg] 61.0 ± 14.0 67.6 ± 12.4 53.6 ± 11.9 60.1 ± 13.6 62.0 ± 14.6
Height [m] 1.7 ± 0.1 1.7 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.7 ± 0.1
FVC [% pred] 96.6
(70.2–140.1)
94.0
(70.2–117.3)
98.8
(77.7–140.1)
96.7
(70.2–114.7)
96.3
(82.6–140.1)
FEV1 [% pred] 94.9
(64.4–118.4)
91.8
(64.4–115.2)
97.3
(69.6–118.4)
95.3
(64.4–111.0)
92.9
(72.6–118.4)
eNO [ppb] 27.5
(5.0–197.0)
27.5
(5.0–197.0)
28.5
(7.0–88.0)
31.5
(6.0–96.0)
20.5
(5.0–197.0)
ACQ   0.7
(0.0–2.9)
0.7
(0.0–2.9)
0.8
(0.0–2.0)
0.9
(0.0–2.9)
0.7
(0.0–2.0)
  1. Normally distributed data mean ± SD; not normally distributed data and % values median and min/max; SD Standard deviation, n Number, yrs Years, m Meter, kg Kilogram, % pred % predicted, ppb Parts per billion